-
Symbol
-
CVAC on Nasdaq
-
Investment type
-
Equity / Common Shares, par value (euro) 0.12 per share
-
Latest Disclosed Ownership
-
0 shares
-
Security Ownership
-
0%
GSK plc ownership in CureVac N.V. Common Shares, par value (euro) 0.12 per share (CVAC)
2025-12-05 - GSK plc has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of CureVac N.V. Common Shares, par value (euro) 0.12 per share (CVAC).
This represents 0% percent ownership of the company.
In their previous filing dated 2025-08-13, GSK plc had reported owning 16.6M shares, indicating a decrease of -100% percent.